The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Drug Infusion Systems Global Market Report 2024, the drug infusion systems market is expected to show promising growth in the forecast period.

The drug infusion systems market is witnessing remarkable growth attributed to various factors including technological advancements, rising prevalence of chronic diseases, and expanding healthcare facilities.

Current Market Overview

• The drug infusion systems market size has experienced robust growth, reaching $12.8 billion in 2023.
• It is projected to expand to $13.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%.

Factors Contributing to Growth

1. Shift to Electronic Infusion Devices
2. Increased Prevalence of Chronic Diseases
3. Patient Care Advancements
4. Expansion of Ambulatory Care Settings
5. Rise in Home-Based Infusion Therapy

Projected Growth and Market Trends

• By 2028, the market is estimated to grow to $18.74 billion at a CAGR of 8.0%.
• Major trends in the forecast period include wireless connectivity, smart pump technology, and personalized dosing.

Surge in Chronic Diseases Propels Market Growth

• Chronic diseases necessitate long-term or continuous infusion therapy.
• Rising prevalence of diseases like diabetes and cancer fuels the demand for drug infusion systems.
• International Diabetes Federation (IDF) predicts a significant increase in diabetes cases by 2045.

Key Players in the Market

• Medtronic PLC
• Baxter International Inc.
• ICU Medical Inc.
• Becton Dickinson and Company
• Smiths Group PLC
• Tandem Diabetes Care Inc.
• Terumo Corporation
• And many more…

View More On The Drug Infusion Systems Market Report 2024 – https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report

Pioneering Drug Delivery Technologies

• Advanced drug delivery technologies are gaining traction in the market.
• Companies like Ivenix are launching smart infusion systems with advanced informatics platforms.
• Fresenius Kabi’s acquisition of Ivenix Inc. for $240 million strengthens its infusion therapy portfolio.

Market Segmentation

1. Product Type
   • Elastomeric Infusion System
   • Disposable Infusion System
   • Syringe Infusion System
   • Peristaltic Pump
   • Multi-Channel Pump
   • Patient-Controlled Analgesia (PCA) Pump
   • Insulin Pump
   • Implantable Infusion System
2. Route of Administration
   • Intravenous
   • Subcutaneous
   • Arterial
   • Epidural
   • Other Routes
3. Application
   • Oncology and Chemotherapy
   • Diabetes
   • Analgesia
   • Nutrition
   • Hematology
   • Pediatrics
   • Other Applications
4. End User
   • Hospitals
   • Ambulatory Surgical Centers
   • Diagnostic Centers
   • Other End Users

Regional Insights

• North America led the market in 2023.
• Asia-Pacific is expected to witness the fastest growth during the forecast period.

Conclusion

The drug infusion systems market is witnessing significant growth driven by technological advancements, rising chronic diseases, and expanding healthcare facilities. As the market evolves, companies are focusing on innovative solutions to meet the growing demand for safe and efficient drug delivery systems. With the projected expansion and emerging trends, the future of drug infusion systems looks promising, offering improved patient care and treatment outcomes worldwide.

Request A Sample Of The Global Drug Infusion Systems Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=10703&type=smp